+44 (0) 1865 606333 enquiries@visibleanalytics.co.uk

Using HTA methods and early value assessment to optimize evidence generation plans

Expert Workshop
February 14th, 2024 – 9am-10am ET / 2:00-3:00pm GMT
moderated by Noemi Muszbek
HE Director, Partner, Visible Analytics

Ascenian and Visible Analytics are co-hosting a live webinar this February.

Join our experts as they answer your questions and explore how early HTA activities and early value assessment can inform asset valuation, investment decisions, study design and market access strategy.

If you require additional information or wish to submit a question to our panellists ahead of live discussion, please email us at enquiries@visibleanalytics.co.uk or info@ascenian-consulting.com.

Prof. Neil Hawkins

Prof. Neil Hawkins

HTA Director, Partner, Visible Analytics, UK

Maryanne Maliwat

Maryanne Maliwat

Sr. Director, Pricing, Reimbursement, & Market Access, Regenxbio, USA

Prof. Dr. Marc Bardou

Prof. Dr. Marc Bardou

Economic and Public Health Committee, HAS, France

Dr. Susanne Michel

Dr. Susanne Michel

former Department of Health in Berlin, Ascenian, Germany